Method of treating cancer using a cMET and AXL inhibitor and an erbB inhibitor

Details for Australian Patent Application No. 2009244453 (hide)

Owner GlaxoSmithKline LLC

Inventors Liu, Li; Gilmer, Tona M.; Shi, Hong; Greger, James G.

Agent Davies Collison Cave

Pub. Number AU-B-2009244453

PCT Pub. Number WO2009/137429

Priority 61/050,322 05.05.08 US

Filing date 5 May 2009

Wipo publication date 12 November 2009

Acceptance publication date 19 July 2012

International Classifications

C07D 413/00 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 401/00 Heterocyclic compounds containing two or more hetero rings

Event Publications

2 December 2010 PCT application entered the National Phase

  PCT publication WO2009/137429 Priority application(s): WO2009/137429

19 July 2012 Application Accepted

  Published as AU-B-2009244453

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009244458-Fertilizer-pesticide throw-pack

2009244448-Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis